Inscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform

Gene editing

Home » Emerging technologies » Gene editing

Cyrus Biotechnology and the Broad Institute of MIT and Harvard Launch Multi-Target Collaboration to Develop Optimized CRISPR Gene Editing Technology

Collaboration aims to produce safer, next-generation CRISPR December 02, 2019 05:30 AM Eastern Standard Time – CAMBRIDGE, Mass. & SEATTLE–(BUSINESS WIRE)–Cyrus Biotechnology, Inc., and the Broad...

Caribou Biosciences Announces New Methods to Harness Type I CRISPR-Cas Systems for Genome Engineering in Human Cells

Video: Leveraging the power of digital genome engineering – Inscripta Workshop at SynBioBeta 2019

Here is the video of the Inscripta Workshop at SynBioBeta 2019 “Leveraging the power of digital genome engineering” with Nandini Krishnamurthy, Senior Director of Microbial Applications at Inscripta. The...

eGenesis Announces $100 Million Series B Financing

Video: Genome-scale mapping of genotype – Inscripta Workshop at SynBioBeta 2019

Fast-forward 10 years from now. What does the CRISPR genome editing field look like to you?

Beam Therapeutics Announces Collaboration and Exclusive License Agreement with Prime Medicine for Prime Editing Technology

How Inscripta’s Onyx platform is making creativity the biologist’s only limiting factor

Top synthetic biology news from academic labs in 2019

How Automation and Machine Learning Help Explore the Dark Corners of the Genome

Synthego Launches High-Throughput Induced Pluripotent Stem Cell Genome Engineering

CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology

Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological Diseases